ArticleWorld journal of gastrointestinal surgery2010
Extent of surgical resections for intraductal papillary mucinous neoplasms.
Article in World journal of gastrointestinal surgery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 43 citations in OpenAlex.
- An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas.Cancers · 2024Review
- Current Endoscopic and Surgical Management of Pancreatic Cystic Lesions: A Comprehensive Review.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024Review
- Mucin-filled CBD, difficult to manage cholangitis.BMJ case reports · 2021Article
- Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection.Digestive diseases and sciences · 2017Review
- Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives.International surgery · 2015Review
- Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.European radiology · 2015Article
- Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2015Article
- Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.Radiation oncology (London, England) · 2014Observational
- Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms.World journal of gastroenterology · 2014Review
- Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs.Gastroenterology research and practice · 2014Review
- IPMN: surgical treatment.Langenbeck's archives of surgery · 2013Review
- Laparoscopic distal pancreatectomy: up-to-date and literature review.World journal of gastroenterology · 2012Review
- [Pathology and classification of intraductal papillary mucinous neoplasms of the pancreas].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2012Review
- Focus on the intraductal papillary mucinous neoplasm of the pancreas.Gastroenterology and hepatology from bed to bench · 2012Review
- Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2011Article
- Intraductal papillary mucinous neoplasm: Coming of age.World journal of gastrointestinal surgery · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraductal papillary mucinous neoplasms (IPMNs) can involve the main pancreatic duct (MD-IPMNs) or its secondary branches (BD-IPMNs) in a segmental of multifocal/diffuse fashion. Growing evidence indicates that BD-IPMNs are less likely to harbour cancer and in selected cases these lesions can be managed non operatively. For surgery, clarification is required on: (1) when to resect an IPMN; (2) which type of resection should be performed; and (3) how much pancreas should be resected. In recent years parenchyma-sparing resections as well as laparoscopic procedures have being performed more frequently by pancreatic surgeons in order to decrease the rate of postoperative pancreatic insufficiency and to minimize the surgical impact of these operations. However, oncological radicality is of paramount importance, and extended resections up to total pancreatectomy may be necessary in the setting of IPMNs. In this article the type and extension of surgical resections in patients with MD-IPMNs and BD-IPMNs are analyzed, evaluating perioperative and long-term outcomes. The role of standard and parenchyma-sparing resections is discussed as well as different strategies in the case of multifocal neoplasms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.